Multivariate analysis of prognostic factors in patients with nodular melanoma.
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
/ therapeutic use
Female
Follow-Up Studies
Humans
Lymphatic Metastasis
Male
Melanoma
/ classification
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
/ drug therapy
Prognosis
Retrospective Studies
Skin Neoplasms
/ classification
Survival Rate
Young Adult
Factors
Logistic regression
Nodular melanoma
Prognostic
Superficial spreading melanoma
Tumor thickness
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
19
01
2021
accepted:
08
02
2021
pubmed:
26
2
2021
medline:
17
8
2021
entrez:
25
2
2021
Statut:
ppublish
Résumé
Nodular melanoma (NM) is associated with worse disease outcome when compared to superficial spreading melanoma (SSM). We aimed to perform a single-center analysis of prognostic factors in patients with NM and compare the data with SSM patients. We studied 228 patients with NN and 396 patients with SSM. Patients with in situ melanomas or stage IV at diagnosis were not included in the study. Data were analyzed using the Mann-Whitney test, Chi-square test, Kaplan-Meier curves including the log-rank test, and logistic regression model. When compared to patients with SSM, patients with NM had less likely lower Clark level, higher tumor thickness, less likely tumor regression, more often ulcerated tumors, and less likely a history of precursor lesions such as a nevus. Within a 5-year follow-up we observed significantly more disease relapses and deaths in NM patients than in SSM patients. On multivariate analysis, disease relapse in NM patients was independently predicted by tumor thickness and positive SLNB, whereas melanoma-specific death of NM patients was independently predicted by male sex and tumor thickness. Histologic regression also remained in the logistic regression model as a significant independent negative predictor of NM death. We did not observe that NM subtype was per se a significant independent predictor for disease relapse or melanoma-specific death. Among the well-known prognostic factors such as tumor thickness and male sex, NM is also associated with other unfavorable factors such as absence of regression.
Identifiants
pubmed: 33630139
doi: 10.1007/s00432-021-03562-1
pii: 10.1007/s00432-021-03562-1
pmc: PMC8310843
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2759-2764Informations de copyright
© 2021. The Author(s).
Références
JAMA Dermatol. 2018 May 1;154(5):544-553
pubmed: 29710122
Med J Aust. 2017 Oct 16;207(8):333-338
pubmed: 29020904
J Natl Cancer Inst. 2019 Feb 1;111(2):180-188
pubmed: 29912415
Melanoma Res. 2016 Oct;26(5):492-6
pubmed: 27380112
Cancer. 1996 Aug 1;78(3):427-32
pubmed: 8697387
Arch Dermatol. 2002 May;138(5):609-14
pubmed: 12020221
Melanoma Res. 2012 Feb;22(1):1-8
pubmed: 22108608
Eur J Cancer. 2018 Mar;92:108-118
pubmed: 29395684
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S78-86
pubmed: 22018071
Ann Surg Oncol. 2017 Jan;24(1):142-149
pubmed: 27646020
J Invest Dermatol. 2016 Jun;136(6):1161-1171
pubmed: 26902923
Arch Dermatol. 2012 Jan;148(1):30-6
pubmed: 21931016
Clin Epidemiol. 2018 May 09;10:537-548
pubmed: 29780262
J Clin Oncol. 2012 May 1;30(13):1462-7
pubmed: 22412152
J Transl Med. 2017 Nov 7;15(1):227
pubmed: 29115977
Cancer. 2004 Nov 1;101(9):2067-78
pubmed: 15372475
JNCI Cancer Spectr. 2020 Oct 23;4(6):pkaa097
pubmed: 33409460
J Natl Cancer Inst. 2019 Dec 1;111(12):1314-1322
pubmed: 30863861
JAMA Dermatol. 2015 Dec 1;151(12):1301-1307
pubmed: 26332402
J Am Acad Dermatol. 2021 Apr;84(4):1015-1022
pubmed: 33253834
J Am Acad Dermatol. 2013 Apr;68(4):568-575
pubmed: 23182058
J Dtsch Dermatol Ges. 2006 Apr;4(4):344-9
pubmed: 16638065
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835